Long-Term Improvement in Patients with moderate to severe atopic Dermatitis treated with Tralokinumab: An ECZTEND Interim Analysis

被引：0
|
作者：
Beissert, Stefan [1 ]
Blauvelt, Andrew [2 ]
Lacour, Jean-Philippe [3 ]
Toth, Darryl [4 ]
Laquer, Vivian [5 ]
Herranz, Pedro [6 ]
Pink, Andrew [7 ]
Peris, Ketty [8 ]
Fangel, Stine [9 ]
Saeki, Hidehisa [10 ]
Wollenberg, Andreas [11 ]
机构：
[1] Univ Klinikum Carl Gustav Carus, Klin & Poliklin Dermatol, Dresden, Germany
[2] Oregon Med Res Ctr, Portland, OR USA
[3] Univ Hosp Nice Cote Azur, Dept Dermatol, Nice, France
[4] Prob Med Res, Windsor, ON, Canada
[5] First OC Dermatol, Fountain Valley, CA USA
[6] La Paz Univ Hosp, Madrid, Spain
[7] Guys & St Thomas Hosp, St Johns Inst Dermatol, London, England
[8] Univ Cattolica Sacro Cuore, Inst Dermatol, Rom, Italy
[9] LEO Pharma AS, Ballerup, Denmark
[10] Nippon Med Sch, Dept Dermatol, Tokyo, Japan
[11] Ludwig Maximilians Univ Munchen, Klinikum LMU Munchen, Klin & Poliklin Dermatol & Allergol, Munich, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2022年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P049
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [41] Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
    Dubini, Marco
    Benzecry, Valentina
    Rivolta, Federica
    Sangalli, Andrea
    Marzano, Angelo Valerio
    Pravettoni, Valerio
    Tavecchio, Simona
    Ferrucci, Silvia Mariel
    FRONTIERS IN ALLERGY, 2023, 4
  • [42] Cost-per-responder analysis of tralokinumab versus dupilumab in patients with moderate-to-severe atopic dermatitis in the US and Canada
    Wu, Jashin J.
    Balu, Sanjeev
    Larsen, Nikolaj Birk
    Pulleyblank, Ryan
    Stromkjaer, Liv
    Quah, Aron
    Wiseman, Marni
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II42 - II43
  • [43] PHARMACOKINETICS OF DUPILUMAB IN LONG-TERM PHASE III STUDIES IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS.
    Davis, J. D.
    Rawal, S.
    Kamal, M.
    Li, M.
    Lai, C. -H.
    Ardeleanu, M.
    DiCioccio, A. T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S61 - S61
  • [44] Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials
    Wollenberg, A.
    Beck, L. A.
    Weller, M. Bruin
    Simpson, E. L.
    Imafuku, S.
    Boguniewicz, M.
    Zachariae, R.
    Olsen, C. K.
    Thyssen, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (03) : 453 - 465
  • [45] Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis
    Prinz, B
    Michelsen, S
    Pfeiffer, C
    Plewig, G
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (04) : 577 - 582
  • [46] ABSENTEEISM IN ADULT PATIENTS WITH MODERATE-TO-SEVERE TREATED ATOPIC DERMATITIS IN PORTUGAL: AN ECONOMETRIC ANALYSIS
    Pinheiro, B.
    Gouveia, M.
    Borges, M.
    VALUE IN HEALTH, 2019, 22 : S902 - S902
  • [47] Tralokinumab real-world patient-reported outcomes in moderate-to-severe atopic dermatitis adult patients in the United States: 6-month interim analysis
    Lio, Peter
    Kim, Yestle
    Balu, Sanjeev
    Costantino, Halley
    Bates, Dawn
    Rene, Cassandra
    Lopez, Amanda
    Soung, Jennifer
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II50 - II51
  • [48] Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry
    Stoelzl, D.
    Boraczynski, N.
    Heratizadeh, A.
    Haufe, E.
    Harder, I.
    Abraham, S.
    Heinrich, L.
    Kleinheinz, A.
    Wollenberg, A.
    Weisshaar, E.
    Schaekel, K.
    Ertner, K.
    Wiemers, F.
    Wildberger, J.
    Worm, M.
    von Kiedrowski, R.
    Effendy, I.
    Asmussen, A.
    Augustin, M.
    Pawlak, M.
    Sticherling, M.
    Zink, A.
    Hilgers, M.
    Handrick, C.
    Quist, S.
    Schwarz, B.
    Staubach-Renz, P.
    Bell, M.
    Hong-Weldemann, S.
    Homey, B.
    Bruecher, J.
    Schmitt, J.
    Werfel, T.
    Weidinger, S.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (02) : E39 - E40
  • [49] PATIENT PERCEPTION OF TREATMENT WITH LONG-TERM DUPILUMAB MONOTHERAPY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Simpson, E.
    Lacour, J.
    Beck, L.
    Zhang, H.
    Aamodt, K.
    Rossi, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S55 - S56
  • [50] Predictive Factors for Poor Responders to Tralokinumab in Moderate-to-Severe Atopic Dermatitis: A Real-World Analysis
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    DERMATITIS, 2025,
12345